Kanamycin Sulfate Injection

Kanamycin Sulfate Injection

kanamycin

Manufacturer:

T. P. Drug

Distributor:

T. P. Drug

Marketer:

Meiji
Concise Prescribing Info
Contents
Kanamycin
Indications/Uses
Initial therapy for serious infections caused by susceptible gm -ve & Staph infections.
Dosage/Direction for Use
IM Reconstitution: 1 g in 3 mL sterile water soln for inj eg, NaCl 0.9%. Susceptible gm -ve & Staph infections Adult 15 mg/kg in 2 divided doses every 12 hr. Paed 7.5 mg/kg in 2 divided doses.
Contraindications
Hypersensitivity to kanamycin & other aminoglycosides.
Special Precautions
Patient w/ neuromuscular disorders (eg, myasthenia gravis, Parkinsonism, or infant botulism), pre-existing vertigo, tinnitus or hearing loss, hypocalcemia. Overgrowth of non-susceptible organisms in prolonged use. Monitor renal & auditory function. Renal impairment. Pregnancy & lactation. Childn, premature infants, neonates.
Adverse Reactions
Ototoxicity, skin rash, drug fever, headache, paraesthesia, nausea, vomiting, diarrhoea, malabsorption syndrome characterised by increased faecal fat, decreased serum carotene, & fall in xylose absorption; IM inj site irritation or pain. Nephrotoxicity, neuromuscular blockade w/ resp paralysis.
MIMS Class
Aminoglycosides
ATC Classification
J01GB04 - kanamycin ; Belongs to the class of other aminoglycosides. Used in the systemic treatment of infections.
Presentation/Packing
Form
Kanamycin Sulfate Injection powd for infusion 1 g
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in